The 33 references in paper G. Mkrtchyan M., L. Hovhannisyan P., A. Ayvazyan A., E. Nazaretyan Y., A. Boyajyan S., Г. Мкртчян М., Л. Оганесян П., А. Айвазян А., Э. Назаретян Е., А. Бояджян С. (2014) “ДИСФУНКЦИЯ СИСТЕМЫ КОМПЛЕМЕНТА ПРИ СЕМЕЙНОЙ СРЕДИЗЕМНОМОРСКОЙ ЛИХОРАДКЕ // DYSFUNCTION OF COMPLEMENT SYSTEM IN FAMILIAL MEDITERRANEAN FEVER” / spz:neicon:mimmun:y:2009:i:1:p:85-90

1
Akcan Y., Bayraktar Y., Arslan S., Van Thiel D.H., Zerrin B.C., Yildiz O. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever // Eur J Med Res. – 2003. – Vol. 8. – P. 304 - 306.
(check this in PDF content)
2
Ayesh S.K., Azar Y., Babior B.M., Matzner Y. Inactivation of Interleukin-8 by the CSa-Inactivating Protease From Serosal Fluid // Blood. – 1993. – Vol. 81, N 6. – P. 1424-1427.
(check this in PDF content)
3
Ben-Chetrit E., Backenroth R., HaimovKochman R., Pizov G. Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis // Ann Rheum Dis. – 1998. – Vol. 57, N 4. – P. 259-260.
(check this in PDF content)
4
Ben-Chetrit E., Familial Mediterranean fever (FMF) and renal AA amyloidosis. Phenotypegenotype correlation, treatment and prognosis // J. Nefrol. – 2003. – Vol. 16. – P. 431-434.
(check this in PDF content)
5
Ben-Chetrit E., Levy M. Colchicine update – 1998 // Semin Arthritis Rheum. – 1998. – Vol. 28. – P. 48-59.
(check this in PDF content)
6
Ben-Chetrit E., Levy M. Familial Mediterranean fever // Lancet. – 1998. – Vol. 351. – P. 659 - 664.
(check this in PDF content)
7
Bíró A., Rovó Z., Papp D., Cervenak L., Varga L., F st G., Thielens N.M., Arlaud G.J., Prohászka Z. Studies on the interactions between C-reactive protein and complement proteins // Immunology. – 2007. – Vol. 121, N 1. – P. 40-50.
(check this in PDF content)
8
Cerquaglia C., Diaco M., Nucera G., La Regina M., Montalto M., Manna R. Pharmacological and clinical basis of treatment of Familial Mediterranean fever (FMF) with colchicine or analogues: an update // Curr. Drug. Targets Inflamm. Allergy. – 2005. – Vol. 4, N 1. – P. 117-124.
(check this in PDF content)
9
French FMF Consortium. A candidate gene for familial Mediterranean fever // Nat. Genet. – 1997. – Vol. 17. – P. 25-31.
(check this in PDF content)
10
Gang N., Drenth J.P., Langevitz P. Activation of the cytokine network in familial Mediterranean fever // J. Rheumatol. – 1999. – Vol. 26. – P. 890 - 897.
(check this in PDF content)
11
Goldfinger S.E. Colchicine for familial Mediterranean fever // N. Engl. J. Med. – 1972. – Vol. 287. – P. 1302.
(check this in PDF content)
12
Holers V.M. The complement system as a therapeutic target in autoimmunity // Clin. Immunol. – 2003. – Vol. 107, N 3. – P. 140-151.
(check this in PDF content)
13
International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever // Cell. – 1997. – Vol. 90. – P. 797-807.
(check this in PDF content)
14
Korkmaz C., Ozdogan H., Kasapcopur O., Yazici H. Acute phase response in familial Mediterranean fever // Ann. Rheum. Dis. – 2002. – Vol. 61, N 1. – P. 79-81.
(check this in PDF content)
15
Le G.T., Abbenante G., Fairlie D.P. Profiling the enzymatic properties and inhibition of human complement factor B // J. Biol. Chem. 2007. – Vol. 282, N 48. – P. 34809-34816.
(check this in PDF content)
16
Lidar M., Scherrman J.M., Shinar Y., Chetrit A., Niel E., Gershoni-Baruch R., Langevitz P., Livneh A. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization // Semin. Arthritis Rheum. – 2004. – Vol. 33, N 4. – P. 273-282.
(check this in PDF content)
17
Linneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T. Criteria for the diagnosis of familial Mediterranean fever // Arthritis Rheum. – 1997. – Vol. 40. – P. 1879-1885.
(check this in PDF content)
18
Matzner Y., Abedat S., Shapiro E., Eisenberg S., Bar-Gil-Shitrit A., Stepensky P., Calco S., Azar Y., Urieli-Shoval S. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures // Blood. – 2000. – Vol. 96, N 2. – P. 727-731.
(check this in PDF content)
19
Medlej-Hashim M., Loiselet J., Lefranc G., Megarbane A. Familial Mediterranean fever (FMF): from diagnosis to treatment // Sante. – 2004. – Vol. 14, N 4. – P. 261-266.
(check this in PDF content)
20
Melamed A., Cabili S., Zakuth V., Spirer Z. The immune regulation in familial Mediterranean fever // J. Clin. Lab. Immunol. – 1988. – Vol. 26. – P. 125-128.
(check this in PDF content)
21
Méry J.P., Kenouch S. Familial Mediterranean fever associated amyloidosis // Renal Failure. – 1993. – Vol. 15. – P. 379-384.
(check this in PDF content)
22
Mkrtchyan G.M., Boyajyan A.S., Ayvazyan A.A., Beglaryan A.A. Classical pathway complement activity in Familial Mediterranean fever // Clin. Biochem. – 2006. – Vol. 39, N 7. – P. 688-691.
(check this in PDF content)
23
Mkrtchyan G.M., Boyajyan A.S., Karageuzyan K.G., Ayvazyan A.A., Pashinyan S.H., Nazaretyan E.Ye. Protein composition of circulating immune complexes in patients with Periodic disease complicated or not complicated by renal amyloidosis // Dokl. Biol. Sci. – 2002. – Vol. 385. – P. 329-330.
(check this in PDF content)
24
Mollnes T.E., Song W.-C., Lambris J.D. Complement in inflammatory tissue damage and disease // Trends Immunol. Today. – 2002. – Vol. 23, N2. – P. 61-66.
(check this in PDF content)
25
Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates // Methods in Molecular Biology. Complement Methods and Protocols / Ed. Morgan B.P. – Humana Press, 2000. – P. 61-71.
(check this in PDF content)
26
Odabas A.R., Cetinkaya R., Selcuk Y., Keles S., Bilen H. Serum C-reactive protein levels during attack-free periods of familial Mediterranean fever // The Pain Clinic – 2002. – Vol. 13, N 4. – P. 319-321.
(check this in PDF content)
27
Schattner A., Lachmi M., Livneh A., Pras M., Hahn T. Tumor necrosis factor in familial Mediterranean fever // Am. J. Med. – 1991. – Vol. 90. – P. 434-438.
(check this in PDF content)
28
Sj berg A.P., Trouw L.A., McGrath F.D., Hack C.E., Blom A.M. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein // J. Immunol. – 2006. – Vol. 176, N 12. – P. 7612-7620.
(check this in PDF content)
29
Szalai A.J., van Ginkel F.W., Wang Y., McGhee J.R., Volanakis J.E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component // J. Immunol. – 2000. – Vol. 165, N 2. – P. 1030-1035.
(check this in PDF content)
30
Oss C.J. The human complement system in health and disease // Marcel Decker. Inc., 1998.
(check this in PDF content)
31
Vinceneux P., Pouchot J. Maladie périodique, symptomatologie clinique et biologique // Presse Med. – 2005. – Vol. 34, N 13. – P. 938-946.
(check this in PDF content)
32
Whaley K., North J. Haemolytic assays for whole complement activity and individual components // Complement. A Practical Approach / Ed. Doods A.W., Sim R.B. – Oxford University Press, 1997. – P. 9-47.
(check this in PDF content)
33
Yalinkaya F., Cakar N., Acar B., Tutar E., Griz H., Elhan A.N., Oztrk S., Kansu A., Ince E., Atalay S., Girgin N., Doru U., Aysev D., Ekim M. The value of the levels of acute phase reactants for the prediction of familial Mediterranean
(check this in PDF content)